Gala vs Zealthy: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Zealthy beats Gala overall, scoring 7.2/10 vs 7/10. Gala is more affordable at $149/mo vs $286/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Zealthy for users who want the option to switch between compounded and b.
A side-by-side comparison of Gala and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaZealthy
#38 of 42Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.
Visit Zealthy| Feature | Gala | Zealthy |
|---|---|---|
| Our Score | 7/10 | 7.2/10 |
| Starting Price | $149/mo | $286/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want the option to switch between compounded and brand-name GLP-1s |
| Ranking | #40 | #38 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Zealthy
Pros
- +Dedicated insurance coordinators handle prior authorizations — potentially bringing brand-name GLP-1 costs to $25/mo
- +Multi-month supply options (3, 6, or 12 months) — unique convenience most monthly-shipping competitors can't match
- +Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
- +LegitScript certified with 4.5-star Review.io rating
Cons
- −$135 membership fee on top of medication cost makes cash-pay total ~$286/mo for semaglutide — above average
- −Young company (founded 2023) with a relatively small review base — less track record than established platforms
- −Prescription products are non-refundable for any reason once ordered
Our Verdict
Zealthy edges out Gala with a score of 7.2/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Zealthy's $286/mo. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.